Microbiology & Infectious Diseases

The Africa CDC and WHO launched a joint continental preparedness plan on the ongoing Ebola outbreak on 5th June 2026.

A novel ‘universal’ Sarbeco coronavirus vaccine has been developed with technology that uses an AI-designed ‘super-antigen’ to provide protection against a broad range of viruses.

Two antidiabetic medications inhibited urinary E. coli growth, reduced biofilm formation, and suppressed virulence associated gene expression in vitro.

Microbial transmission and oral microbiota alterations might have links to immune changes in pregnancy.

Stress may accelerate hepatocellular carcinoma progression by altering gut microbiota and tumour immune signalling, according to new preclinical and clinical research identifying a stress–gut–tumour axis.

Amid promising developments in prevention and diagnostics, barriers persist for vulnerable groups, a WHO expert told EMJ at the 79th World Health Assembly.

A new study suggests Pseudomonas aeruginosa in chronic lung disease often exists as a single clonal strain, supporting current antibiotic strategies.

HIV cases continue to rise across the Middle East and North Africa despite progress in prevention and treatment, with stigma and inequality limiting care access for LGBTQIA+ communities.